Ayuda-Durán, Pilar http://orcid.org/0000-0002-9799-3680
Hermansen, Johanne U. http://orcid.org/0000-0003-3830-2277
Giliberto, Mariaserena
Yin, Yanping
Hanes, Robert http://orcid.org/0000-0001-6544-2182
Gordon, Sandra http://orcid.org/0000-0003-0270-8291
Kuusanmäki, Heikki
Brodersen, Andrea M.
Andersen, Aram N.
Taskén, Kjetil http://orcid.org/0000-0003-2841-4697
Wennerberg, Krister
Enserink, Jorrit M.
Skånland, Sigrid S. http://orcid.org/0000-0003-1630-356X
Funding for this research was provided by:
Norges Forskningsråd
Kreftforeningen
Stiftelsen Kristian Gerhard Jebsen
Kræftens Bekæmpelse
Article History
Received: 13 July 2023
Revised: 21 October 2023
Accepted: 13 November 2023
First Online: 1 December 2023
Competing interests
: SSS has received honoraria from AbbVie and AstraZeneca, and research support from BeiGene and TG Therapeutics. The other authors declare no competing interests.
: The study was approved by the Regional Committee for Medical and Health Research Ethics of South-East Norway. All donors signed a written informed consent prior to sample collection. The research on human blood was carried out in accordance with the Declaration of Helsinki.